Canada: Afexa Life Sciences Inc. Shareholder Rights Plan Survives To End Of "Go Shop" Period


The Alberta Securities Commission (ASC) was the first Canadian tribunal to consider the effect of a "go shop" provision on a shareholder rights plan (SRP) in Re Afexa Life Sciences Inc.1, a written decision released on October 14, 2011. The ASC held that the SRP should be allowed to survive to the end of the "go shop" period and rejected other more conventional arguments that the SRP should survive for a longer period.


Afexa Life Sciences Inc. (Afexa) the manufacturer of Cold FX, a popular remedy for the common cold, adopted its first SRP (SRP I) at its annual meeting in 2010. SRP I was triggered by the acquisition of 20% of Afexa common shares other than by a "Permitted Bid". A Permitted Bid must remain open for 60 days and have a minimum tender condition of greater than 50%.

Paladin Labs Inc. (Paladin) made a hostile bid for Afexa on August 10, 2011. Prior to making its hostile bid, Paladin had acquired 14.95% of the common shares of Afexa in the open market. Paladin's bid was for $0.55 or 0.013 Paladin common share per Afexa common share. Paladin's bid was for "any or all" Afexa shares with no minimum tender condition.

The Afexa Board concluded that the Paladin bid was inadequate and coercive to Afexa shareholders because of the absence of a minimum tender condition. Further, the Afexa Board determined that the size of Paladin's shareholding in Afexa was a threat to the emergence of competitive bids given that Afexa was widely held and thinly traded.

To address its concerns with the Paladin bid, the Afexa Board adopted a strategic shareholder rights plan (SRP II). The terms of SRP II were substantially the same as SRP I except that it was triggered by the acquisition of 15% of Afexa's common shares rather than 20%. SRP II was not put to Afexa shareholders prior to the ASC hearing.

On August 30, 2011, Valeant Pharmaceuticals International (Valeant) made an offer to acquire Afexa common shares for $0.71 each. Afexa and its directors and officers concluded a Support Agreement with Valeant. The Support Agreement provided that Afexa had a 30 day "go shop" period in which it could solicit alternative transactions. After the expiry of the 30 day "go shop" period, a "no shop" period would commence. The Support Agreement gave Valeant a 5 day period within which it was allowed to match any superior offers and a $3.75 million break fee in the event that Afexa accepted a superior proposal.

Positions of the Parties

Three main arguments were advanced in favour of the survival of SRP II. First, it was submitted that SRP II should survive to the end of the "go shop" period. Afexa contended that the Afexa Board had determined that 30 days was the period required to expose the company to the market to obtain alternative proposals. The ASC, it was submitted, should not second guess the Afexa Board's judgment. It was further submitted that "go shop" provisions are shareholder-friendly but relatively uncommon in Canada. As such, as a matter of policy the ASC should render a decision that encourages the use of "go shop" provisions in the future.

Second, Afexa submitted that Paladin should be restricted to the 15% threshold in SRP II for an unspecified time past the end of the "go shop" period so that it could not obtain a blocking position and undermine the existing bidder or potential bidders.

Third, it was argued that the Paladin bid was coercive because it was for "any or all" Afexa common shares. Paladin, it was submitted, could gain effective control of Afexa with an increased bid without giving Afexa common shareholders who opposed the Paladin bid any guaranteed way to exit their investment. As a result, it was speculated that Afexa shareholders might tender their shares to an increased Paladin bid out of fear that there would be no extension of the Paladin bid or second stage transaction.

ASC Decision

The ASC held that SRP II should be ceased traded immediately following the expiry of the "go shop" period which was only six days after the hearing. The ASC concluded that the SRPs together with the "go shop" provision "worked in the interests of Afexa shareholders by enabling Afexa to generate an additional bid." However, the ASC also concluded that the auction was at or nearing an end. While the ASC acknowledged that the Afexa Board had fulfilled its fiduciary obligations and that some deference to the Afexa Board was warranted, the ASC's decision was based on its assessment of the public interest. Despite the ASC's express conclusions, it seems clear that the existence of the "go shop" affected the ASC's decision regarding the timing of the cease trade of SRP II.

The ASC's decision raises the question of what a securities commission would do if an application to cease trade an SRP is brought early in a "go shop" period. Would a securities commission be prepared to allow an SRP to survive 30 or more days to allow further alternative transactions to be sourced? While commissions have not traditionally deferred to the business judgment of a target company's board of directors, the existence of a "go shop" period negotiated with a bona fide bidder with an interest in ending an auction is harder for a commission to ignore.

The ASC rejected Afexa's position that Paladin should be limited to a 15% ownership threshold and that SRP II should survive past the end of the "go shop" for this purpose. The panel noted that 20% ownership is the threshold for the take-over provisions in the Securities Act and was also the threshold selected by the Afexa for SRP I. The evidence before the panel did not persuade them that a lower threshold was necessary to prevent Paladin from obtaining a blocking position.

The ASC rejected the argument that the Paladin bid was coercive and that SRP II should survive past the end of the "go shop" period. The ASC held that bids without a minimum tender condition are not inherently coercive. Indeed, the ASC concluded that such bids are not different in principle from the more common form of bid that has a waiveable minimum tender condition. The ASC refused to speculate as to what Paladin might do in the future and noted that, as a practical matter, Afexa shareholders were not being coerced because the evidence was that they could exit their investment during the course of the bidding process by selling their shares into the market at a price in excess of any of the bids.


1 Osler was counsel to the Special Committee of the Afexa Life Sciences Inc. Board of Directors.

Colin Feasby represents clients in corporate and securities litigation, energy industry disputes, franchise litigation, and constitutional matters. Noralee Bradley practice focuses on mergers and acquisitions, public and private placement financings, corporate and board governance and the purchase and sale of assets and shares. Tristram Mallett practice focuses on corporate litigation, class action defence and securities enforcement.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.